114
Views
5
CrossRef citations to date
0
Altmetric
Case Reports

Cancer-associated Retinopathy Developing After 10 Years of Complete Breast Cancer Remission

, , &
Pages 36-42 | Received 19 Jan 2018, Accepted 31 Mar 2018, Published online: 23 May 2018

References

  • Gordon LK. Paraneoplastic syndromes in neuro-ophthalmology. J Neuro-Ophthalmol. 2015;35(3):306–314. doi:10.1097/WNO.0000000000000280.
  • Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: a review and summary. Semin Immunopathol. 2008;30(2):127–134. doi:10.1007/s00281-008-0114-7.
  • Grewal DS, Fishman GA, Jampol LM. Autoimmune retinopathy and antiretinal antibodies: a review. Retina. 2014;34(5):827–845. doi:10.1097/IAE.0000000000000119.
  • Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol. 2013;58(5):430–458. doi:10.1016/j.survophthal.2012.09.001.
  • Adamus G. Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer. Invest Ophthalmol Vis Sci. 2015;56(3):1680–1688. doi:10.1167/iovs.14-15739.
  • Thirkill CE. Cancer-induced, immune-mediated ocular degenerations. Ocul Immunol Inflamm. 2005;13(2–3):119–131. doi:10.1080/09273940590928733.
  • Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol. 2003;48(1):12–38. doi:10.1016/S0039-6257(02)00416-2.
  • Adamus G. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev. 2009;8(5):410–414. doi:10.1016/j.autrev.2009.01.002.
  • Maeda A, Ohguro H, Maeda T, et al. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Cancer Res. 2000;60(7):1914–1920.
  • Matsuo S, Ohguro H, Ohguro I, Nakazawa M. Clinicopathological roles of aberrantly expressed recoverin in malignant tumor cells. Ophthalmic Res. 2010;43(3):139–144. doi:10.1159/000253486.
  • Maeda T, Maeda A, Maruyama I, et al. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 2001;42(3):705–712.
  • Makiyama Y, Kikuchi T, Otani A, et al. Clinical and immunological characterization of paraneoplastic retinopathy. Invest Ophthalmol Vis Sci. 2013;54(8):5424–5431. doi:10.1167/iovs.13-11868.
  • Ohnishi Y, Ohara S, Sakamoto T, Kohno T, Nakao F. Cancer-associated retinopathy with retinal phlebitis. Br J Ophthalmol. 1993;77(12):795–798. doi:10.1136/bjo.77.12.795.
  • Kim SJ, Toma HS, Thirkill CE, Dunn JP Jr. Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer. Ocul Immunol Inflamm. 2010;18(2):107–109. doi:10.3109/09273940903457441.
  • Anastasakis A, Dick AD, Damato EM, Spry PG, Majid MA. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction. Documenta Ophthalmologica Advanc Ophthalmol. 2011;123(1):59–63. doi:10.1007/s10633-011-9277-y.
  • Cao R, Cao Y. Cancer-associated retinopathy: a new mechanistic insight on vascular remodeling. Cell Cycle. 2010;9(10):1882–1885. doi:10.4161/cc.9.10.11521.
  • Lima LH, Greenberg JP, Greenstein VC, et al. Hyperautofluorescent ring in autoimmune retinopathy. Retina. 2012;32(7):1385–1394. doi:10.1097/IAE.0b013e3182398107.
  • Murphy MA, Thirkill CE, Hart WM Jr. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma. J Neuro-Ophthalmol. 1997;17(2):77–83. doi:10.1097/00041327-199706000-00001.
  • Keltner JL, Thirkill CE, Tyler NK, Roth AM. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol. 1992;110(1):48–53. doi:10.1001/archopht.1992.01080130050025.
  • Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol. 1999;117(4):471–477. doi:10.1001/archopht.117.4.471.
  • Dy I, Chintapatla R, Preeshagul I, Becker D. Treatment of cancer-associated retinopathy with rituximab. J Natl Compr Cancer Netw. 2013;11(11):1320–1324. doi:10.6004/jnccn.2013.0156.
  • Ohguro H, Yokoi Y, Ohguro I, et al. Clinical and immunologic aspects of cancer-associated retinopathy. Am J Ophthalmol. 2004;137(6):1117–1119. doi:10.1016/j.ajo.2004.01.010.
  • Gass JD, Agarwal A, Scott IU. Acute zonal occult outer retinopathy: a long-term follow-up study. Am J Ophthalmol. 2002;134(3):329–339. doi:10.1016/S0002-9394(02)01640-9.
  • Mrejen S, Khan S, Gallego-Pinazo R, Jampol LM, Yannuzzi LA. Acute zonal occult outer retinopathy: a classification based on multimodal imaging. JAMA Ophthalmol. 2014;132(9):1089–1098. doi:10.1001/jamaophthalmol.2014.1683.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.